Biotech Values

[ilpapa]

I missed out on increasing my ARIA position, unfortunately, and am actually down to a core position. I recognize the importance of the 113 news but am generally cautious against the background of an uncertain market. Which means I'm on the side of raising cash rather than deploying it. From which it follows that I may be missing the boat.
DVAX is simply too strange to venture a guess as to what might be going on. They certainly are not signaling a buyout. Why accept such a haircut (roughly 15%) unless they are cash constrained, which they don't seem to be. Bizarre.